Durham, N.C.-based antimicrobial textile technology provider PurThread Technologies Inc. and Rochester, N.Y.-based Eastman Kodak Co. have signed a globally exclusive agreement with under which PurThread will embed Kodak's antimicrobial ...
Tags: PurThread, Kodak, antimicrobial, technology, Textile
In my article The 5 best natural antibiotics and anti-virals that destroy superbugs and just about everything else, I discuss some of the best natural substances for treating MRSA and other antibiotic-resistant bacteria. Natural News ...
Tags: herbal, antibiotic, anti-viral, MRSA, bacteria, pathogen
Waste-water treatment by-products, also known as sewage sludge, are frequently used as fertilizer. And that means whatever this stew of sewage leftovers contains, including substances hazardous to human and animal health, could potentially ...
Tags: antibiotic, resistant, bacteria, fertilizer, super bug
Cystic Fibrosis Foundation Therapeutics (CFFT), an affiliate of the CF Foundation, has provided $1.7m research award to US-based Savara Pharmaceuticals for advancing the development of AeroVanc (vancomycin hydrochloride inhalation powder). ...
IntelligentMDx (IMDx) has received the US Food and Drug Administration (FDA) approval for its second automated molecular diagnostic test for use on Abbott's fully automated m2000 platform. The automated molecular diagnostic test detects ...
IntelligentMDx has secured clearance from the US Food and Drug Administration (FDA) for IMDx VanR for Abbott m2000 assay, an automated molecular diagnostic test that detects the presence of vanA and vanB genes associated with ...
Rib-X Pharmaceuticals, Ligand Pharmaceuticals' partner, has commenced Phase 3 trial of a Captisol-enabled intravenous (IV) formulation of delafloxacin to treat acute bacterial skin and skin structure infections (ABSSSI). According to the ...
Tags: Rib-X, Pharmaceuticals
Optimer Pharmaceuticals has announced the approval of Dificid (fidaxomicin) Tablets by the Australian regulatory body, the Therapeutic Goods Administration. Specialised Therapeutics Australia that has license to fidaxomicin in Australia ...
BioFire Diagnostics has submitted 510(k) pre-market notification application to the US Food and Drug Administration (FDA) seeking approval for its FilmArray blood culture identification (BCID) test. The application included positive ...
Tags: Biofire, FDA Clearance
Watson Laboratories, a subsidiary of Watson Pharmaceuticals, has received FDA approval for its abbreviated new drug application for Vancomycin hydrochloride capsules, USP, 125mg and 250mg. The company has begun the shipment of the product ...
The US Food and Drug Administration (FDA) has granted de novo petition to market Nanosphere's gram-positive blood culture nucleic acid test (BC-GP) on the automated sample-to-result Verigene system. Single automated BC-GP test detects ...
Tags: Nanosphere, FDA, BC-GP test, Verigene system
IntelligentMDx has received CE mark approval for its automated molecular HSV-1/2 test, designed for the Abbott m2000 system. The HSV-1/2 for Abbott m2000 assay detects Herpes Simplex Virus (HSV) viral DNA and differentiates HSV-1 and ...
Tags: IntelligentMDx, HSV-1/2 test, Abbott m2000 system, HSV
MicuRx Pharmaceuticals has received a US patent from the USPTO covering the composition of its clinical candidate, MRX-I. The antibacterial oxazolidinone targets infections due to multi-drug resistant Gram-positive pathogens. MicuRx ...
Tags: MicuRx Pharmaceuticals, MRX-I
Astellas Pharma Europe, a European subsidiary of Astellas, has introduced Dificlir (generic name: fidaxomicin) tablets in the Europe. Dificlir, indicated to treat Clostridium difficile infections (CDI), is an orally administered, ...
Tags: Dificlir, fidaxomicin, CDI
The US Food and Drug Administration(FDA)has granted orphan drug designation to Savara Pharmaceuticals'first inhaled antibiotic,designed for the treatment of pulmonary methicillin-resistant Staphylococcus aureus(MRSA)infection in cystic ...
Tags: Orphan Drug, Savara Pharma, FDA, inhaled antibiotic, MRSA